Sam Ropp is Chief Commercial Officer of Singular Genomics Systems, Inc.. Currently has a direct ownership of 16,750 shares of OMIC, which is worth approximately $223,110. The most recent transaction as insider was on Mar 15, 2024, when has been sold 4,187 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.8K
0% 3M change
100.0% 12M change
Total Value Held $223,110

Sam Ropp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
4,187 Added 20.0%
16,750 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
-
4,188 Added 25.0%
12,563 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
-
4,187 Added 33.33%
8,375 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
4,188 Added 50.0%
4,188 Common Stock
SR

Sam Ropp

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on OMIC

Follow Singular Genomics Systems, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OMIC shares.

Notify only if

Insider Trading

Get notified when an Singular Genomics Systems, Inc. insider buys or sells OMIC shares.

Notify only if

News

Receive news related to Singular Genomics Systems, Inc.

Track Activities on OMIC